Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/10007
Title: Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome
Authors: Alihanoglu, Y.I.
Yildiz, B.S.
Özcan, E.E.
Kilic, D.I.
Kuru, D.S.
Taskoylu, O.
Tanriverdi, H.
Keywords: Coronary flow rate
Homocysteine
Metabolic syndrome
TIMI frame count
homocysteine
biological marker
adult
angiocardiography
Article
blood clot lysis
clinical assessment
clinical evaluation
controlled study
coronary artery
coronary artery blood flow
coronary risk
correlational study
female
heart infarction
human
hyperhomocysteinemia
hyperlipidemia
left anterior descending coronary artery
left circumflex artery
major clinical study
male
metabolic syndrome X
right coronary artery
risk factor
blood
causality
Coronary Stenosis
middle aged
prevalence
reproducibility
sensitivity and specificity
Turkey
Biomarkers
Causality
Female
Humans
Male
Metabolic Syndrome X
Middle Aged
Prevalence
Reproducibility of Results
Risk Factors
Sensitivity and Specificity
Publisher: Springer-Verlag Wien
Abstract: Background: Metabolic syndrome (MS) refers to a group of cardiovascular risk factors associated with endothelial dysfunction and impaired coronary blood flow (CBF). Homocysteine (Hcy) is another risk factor for the development of insulin resistance and endothelial dysfunction. However, the relationship between Hcy levels and CBF in patients with MS has not been investigated specifically. In the present study, we aimed to evaluate the relationship between Hcy levels and CBF in MS patients with normal coronary arteries. Methods: The study population included 36 patients with MS (20 males, 16 females; mean age = 55 ± 9 years) and 36 control subjects (20 males, 16 females; mean age = 51 ± 7 years). All subjects had angiographically proven normal coronary arteries. Plasma Hcy concentrations were evaluated after a fast of 12 h or longer. The CBF rates of all subjects were documented by the thrombolysis in myocardial infarction (TIMI) frame count method. Results: The TIMI frame counts for each major epicardial coronary artery and mean TIMI frame count were found to be significantly higher in the MS group compared with the control group (left anterior descending coronary artery (LAD): 53 ± 26 vs. 39 ± 17; p = 0.01, left circumflex artery (LCx): 32 ± 12 vs. 26 ± 11; p = 0.01, right coronary artery (RCA): 33 ± 14 vs. 26 ± 12; p = 0.02, mean TIMI frame count: 39 ± 16 vs. 20 ± 12; p = 0.01). Plasma Hcy levels in patients with MS were significantly higher compared with controls (MS group = 11.6 ± 4 and control group = 9.6 ± 2.6; p = 0.01). Additionally, plasma Hcy levels were positively correlated with each calculated TIMI frame count value in the MS group (LAD, r: 0.28 and p = 0.006; LCx, r: 0.25 and p = 0.022; RCA, r: 0.26 and p = 0.042; mean TIMI frame count, r: 0.28 and p = 0.004). Conclusion: Plasma Hcy levels and TIMI frame counts were significantly higher in patients with MS. Impaired CBF in MS may be related to elevated levels of Hcy, even if Hcy levels are normal. © 2015, Springer-Verlag Wien.
URI: https://hdl.handle.net/11499/10007
https://doi.org/10.1007/s00508-015-0854-z
ISSN: 0043-5325
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

3
checked on Nov 16, 2024

WEB OF SCIENCETM
Citations

3
checked on Nov 21, 2024

Page view(s)

38
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.